Cdc20 inhibitor apcin inhibits the growth and invasion of osteosarcoma cells

44Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

Abstract

Osteosarcoma (OS) is the most common primary malignant bone tumor worldwide, primarily affecting children and adolescents. The anaphase promoting complex/cyclosome (APC/C) is a ubiquitin ligase that is activated by its co-activator Cdc20 during the metaphase-anaphase transition. Apcin is a novel cell-permeable molecule that blocks the interaction between APC/C and Cdc20. Cdc20 overexpression has been reported in various malignancies and plays an oncogenic role in tumorigenesis and tumor progression. In the present study, the antitumor properties of apcin, an inhibitor of Cdc20, was investigated in OS cell lines. In addition, the possible molecular target by which apcin mediates cell death was explored. Apcin was demonstrated to inhibit OS cell growth and induce significant apoptosis. The invasion and mobile abilities of OS cells were also markedly suppressed by apcin treatment. Furthermore, Bim and p21 were upregulated in OS cells following apcin treatment. The results of the present study indicated that apcin may have therapeutic potential as a treatment for OS and that Cdc20 may be a promising molecular target for chemotherapy.

References Powered by Scopus

Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols

1937Citations
N/AReaders
Get full text

Bim: A novel member of the Bcl-2 family that promotes apoptosis

986Citations
N/AReaders
Get full text

Cell death induced by endoplasmic reticulum stress

809Citations
N/AReaders
Get full text

Cited by Powered by Scopus

APC/C ubiquitin ligase: Functions and mechanisms in tumorigenesis

64Citations
N/AReaders
Get full text

Mitosis inhibitors in anticancer therapy: When blocking the exit becomes a solution

64Citations
N/AReaders
Get full text

Overexpression of ASPM, CDC20, and TTK Confer a Poorer Prognosis in Breast Cancer Identified by Gene Co-expression Network Analysis

61Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Gao, Y., Zhang, B., Wang, Y., & Shang, G. (2018). Cdc20 inhibitor apcin inhibits the growth and invasion of osteosarcoma cells. Oncology Reports, 40(2), 841–848. https://doi.org/10.3892/or.2018.6467

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 10

71%

Researcher 4

29%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 7

58%

Chemistry 2

17%

Agricultural and Biological Sciences 2

17%

Pharmacology, Toxicology and Pharmaceut... 1

8%

Save time finding and organizing research with Mendeley

Sign up for free